HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Immunologic transformation against pertussis in children following a second revaccination with ADPT-vaccine].

Abstract
Immunological reconstruction was studied in children aged 6 years after the second revaccination with absorbed, pertussis-diphtheria-tetanus vaccine (APDT) in a strictly controlled trial. Antipertussis protective antibodies were determined in the sera in the passive hemagglutination test and the antigen neutralization test, whose results were characterized by the following regularities: the average (1:160--1:640) and the high (1:1280 and over) antibody titres were recorded 1 to 1.5 months after the vaccination in 46.9--48.9% of the persons vaccinated. Determination of the changes of the immunoglobulins A, M, and G at various periods after the second revaccination demonstrated that 1 to 1.5 months after the revaccination (that is at the peak of the antipertussis antibodies formation) 55.7--50.0% of the children displayed an elevation of the IgA and IgM against the background of the IgG reduction in 69.7% of cases.
AuthorsE A Baeva, I Z Aleksandrova, T S Selezneva
JournalZhurnal mikrobiologii, epidemiologii i immunobiologii (Zh Mikrobiol Epidemiol Immunobiol) Issue 2 Pg. 104-8 (Feb 1977) ISSN: 0372-9311 [Print] Russia (Federation)
Vernacular TitleOsobennosti immunologicheskoĭ perestroĭki protiv kokliusha u deteĭ posle vtoroĭ revaktsinatsii AKDS-vaktsinoĭ
PMID857515 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Bacterial
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Pertussis Vaccine
Topics
  • Antibodies, Bacterial (analysis)
  • Child
  • Hemagglutination Tests
  • Humans
  • Immunization Schedule
  • Immunization, Secondary
  • Immunoglobulin A (analysis)
  • Immunoglobulin G (analysis)
  • Immunoglobulin M (analysis)
  • Neutralization Tests
  • Pertussis Vaccine (administration & dosage)
  • Time Factors
  • Whooping Cough (immunology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: